|
´º¹é¼ÒºñµåÇÁ¸®Çʵå½Ã¸°Áö(»ç½ºÄڷγª¹ÙÀÌ·¯½º-2 Ç¥¸éÇ׿ø ¹é½Å) | »ç½º Äڷγª¹ÙÀÌ·¯½º-2 ½ºÆÄÀÌÅ© ´Ü¹éÁú(À¯ÀüÀÚÀçÁ¶ÇÕ)(¼÷ÁÖ: Sf9, º¤ÅÍ: BV2373) 5§¶ | Àü¹® | ºñ±Þ¿© |
|
½ºÄ«À̹ٸ®¼¿¶óÁÖ | Live Attenuated Varicella Virus(¹ÙÀÌ·¯½ºÁÖ:Oka/SK, ¼¼Æ÷ÁÖ:MRC-5) 2400PFUÀÌ»ó | Àü¹® | ºñ±Þ¿© |
|
½ºÄ«À̼¿Ç÷ç4°¡ÇÁ¸®Çʵå½Ã¸°Áö(¼¼Æ÷¹è¾çÀÎÇ÷翣ÀÚÇ¥¸éÇ׿ø¹é½Å) | purified inactivated influenza virus antigen B 15§¶ ¿Ü 3°³ | Àü¹® | ºñ±Þ¿© |
|
½ºÄ«ÀÌÁ¶½ºÅÍÁÖ(´ë»óÆ÷Áø»ý¹ÙÀÌ·¯½º¹é½Å) | attenuated live varicella virus 27400 PFU ÀÌ»ó | Àü¹® | ºñ±Þ¿© |
|
½ºÄ«ÀÌÄÚºñ¿ø¸ÖƼÁÖ | SARS-CoV-2 Spike Protein Receptor Binding Domain (Recombinant) 250¥ìg | Àü¹® | ºñ±Þ¿© |
|
Çѱ¹¾Æ½ºÆ®¶óÁ¦³×Ä«¹é½ºÁ¦ºê¸®¾ÆÁÖ | Recombinant Chimpanzee Adenovirus Vector encoded Ox1-Spike Protein 2.5¡¿10^9 | Àü¹® | ºñ±Þ¿© |
|
ÇìÆĹÃÁÖ0.5ml | Purified Hepatitis B Surface Antigen Protein 20¥ìg(10¥ìg) | Àü¹® | ºñ±Þ¿© |
|
ÇìÆĹÃÁÖ1ml | Purified Hepatitis B Surface Antigen Protein 20¥ìg(10¥ìg) | Àü¹® | ºñ±Þ¿© |
|
ÇìÆĹÃÇÁ¸®Çʵå½Ã¸°Áö1ml | Purified Hepatitis B Surface Antigen Protein 20¥ìg | Àü¹® | ºñ±Þ¿© |